In the thick of it: parameters for glaucoma detection

Article

Macular ganglion cell complex (mGCC) and peripapillary retinal nerve fiber layer (ppRNFL) thickness can be used as structural parameters for detecting preperimetric glaucoma.

Macular ganglion cell complex (mGCC) and peripapillary retinal nerve fiber layer (ppRNFL) thickness can be used as structural parameters for detecting preperimetric glaucoma, reveals a study in the Journal of Glaucoma.

The investigation, led by Dr S.T. Takagi, Department of Ophthalmology, Toho University School of Medicine Faculty of Medicine, Tokyo, Japan, was held in a single institution and included 50 eyes of 50 glaucoma patients with visual field defects limited to the superior or inferior hemifield.

There were also 25 eyes of 25 control participants matched for age, sex and refractive errors. Thickness was measured in three areas using the automatic algorithm of a spectral-domain optical coherence tomography system.

Defective and normal hemifield values were compared, along with the correlation between OCT parameters and the total deviation values of the parameters in the Humphrey visual field.

mGCC thickness in the normal hemifield in glaucomatous eyes was significantly lower than in the control eyes. However, there was no significant difference in total thickness of the macular retinas between glaucomatous eyes and control eyes. In the normal hemisphere the mGCC and ppRNFL thicknesses were significantly correlated with total deviation in the visual field paramters.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.